Kerri Fitzgerald

DocwireNews

Research on tranexamic acid (TXA) suggests it is effective in reducing blood loss during total joint arthroplasty (TJA). During a poster presentation at the AAOS 2018 Annual Meeting, researchers from Rush University Medical Center detailed a network meta-analysis to explore the use of TXA in primary TJA on behalf of a consensus statement from the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and American Society of Regional Anesthesia.The researchers conducted a literature review of OVID-MEDLINE, EMBASE, Cochrane Reviews, SCOPUS, and Web of Science databases for all publications on TXA in primary TJA before October 2016, and identified 1,767 articles. Direct and indirect comparisons were performed for all treatments, and the results of the analysis were tested for consistency.After critical appraisal using the Consolidated Standards Of Reporting Trials assessment of the available publications, the researchers only included the best available evidence. Topical, intravenous, and oral TXA formulations were all statistically superior to placebo for blood loss and risk of transfusion. TXA reduced blood loss and the risk of transfusion regardless the dose timing compared with placebo (p&lt;0.05 for all). No difference was observed between all TXA formulations and placebo for risk of thromboembolic events (p&lt;0.05 for all).&ldquo;We conclude [that] the routine use of TXA in the setting of a primary TJA is safe and effective for nearly all patients,&rdquo; the authors noted.

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

The Role of Tranexamic Acid in Total Joint Arthroplasty

AAOS 2018 Annual Meeting

Research on tranexamic acid (TXA) suggests it is effective in reducing blood loss during total joint arthroplasty (TJA). During a poster presentation at the AAOS 2018 Annual ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe